{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:50:29Z","timestamp":1787579429732,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ejca.2015.03.015","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T12:32:57Z","timestamp":1431433977000},"page":"1405-1414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":259,"title":["Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17"],"prefix":"10.1016","volume":"51","author":[{"given":"S.Y.","family":"Brul\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Karapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.C.","family":"Tebbutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cr.","family":"Underhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Zalcberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2015.03.015_b0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.ejca.2015.03.015_b0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","article-title":"Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location","volume":"113","author":"Bufill","year":"1990","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ejca.2015.03.015_b0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.10635","article-title":"Are there two sides to colorectal cancer?","volume":"101","author":"Iacopetta","year":"2002","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2015.03.015_b0020","first-page":"A4444","article-title":"Possible better long-term survival in left versus right-sided colon cancer \u2013 a systematic review","volume":"59","author":"Hansen","year":"2012","journal-title":"Dan Med J"},{"issue":"3","key":"10.1016\/j.ejca.2015.03.015_b0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejso.2014.11.001","article-title":"Is right-sided colon cancer different to left-sided colorectal cancer? \u2013 A systematic review","volume":"41","author":"Lee","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"33","key":"10.1016\/j.ejca.2015.03.015_b0030","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1200\/JCO.2011.36.4414","article-title":"Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results\u2013medicare data","volume":"29","author":"Weiss","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2015.03.015_b0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","article-title":"Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival","volume":"53","author":"Benedix","year":"2010","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.ejca.2015.03.015_b0040","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/ijc.25258","article-title":"Colon cancer in iceland\u2013a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age","volume":"127","author":"Snaebjornsson","year":"2010","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2015.03.015_b0045","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1463-1318.2010.02356.x","article-title":"Outcome of right- and left-sided colonic and rectal cancer following surgical resection","volume":"13","author":"Suttie","year":"2011","journal-title":"Colorectal Dis"},{"issue":"3","key":"10.1016\/j.ejca.2015.03.015_b0050","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1440-1746.2007.04923.x","article-title":"Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology","volume":"23","author":"Nawa","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.ejca.2015.03.015_b0055","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1463-1318.2012.03048.x","article-title":"The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer","volume":"14","author":"Powell","year":"2012","journal-title":"Colorectal Dis"},{"issue":"9","key":"10.1016\/j.ejca.2015.03.015_b0060","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1245\/s10434-008-0015-y","article-title":"Is there a difference in survival between right- versus left-sided colon cancers?","volume":"15","author":"Meguid","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejca.2015.03.015_b0065","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","article-title":"Cetuximab for the treatment of colorectal cancer","volume":"357","author":"Jonker","year":"2007","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ejca.2015.03.015_b0070","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2015.03.015_b0075","doi-asserted-by":"crossref","unstructured":"Missiaglia E, Jacobs B, Di Narzo A, et al. Proximal and distal colon tumors as distinct biologic entities with different prognoses. 2013 ASCO Annual Meeting. 2013;Abstract 3526.","DOI":"10.1200\/jco.2013.31.15_suppl.3526"},{"key":"10.1016\/j.ejca.2015.03.015_b0080","unstructured":"Heinemann V, Modest DP, von Weikersthal LF, et al. Gender and tumor location as predictors for efficacy: Influence on endpoints in first-line treatment with FOLFIRI in combination with cetuximab or bevacizumab in the AIO KRK 0306 (FIRE3) trial. J Clin Oncol 32:5s, 2014 (suppl.; abstr 3600). 2014 ASCO Annual Meeting."},{"issue":"9","key":"10.1016\/j.ejca.2015.03.015_b0085","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00432-014-1678-3","article-title":"Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12\/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial","volume":"140","author":"von Einem","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ejca.2015.03.015_b0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00384-006-0093-x","article-title":"Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis","volume":"22","author":"Azzoni","year":"2007","journal-title":"Int J Colorectal Dis"},{"issue":"8","key":"10.1016\/j.ejca.2015.03.015_b0095","first-page":"755","article-title":"Distinguishing right from left colon by the pattern of gene expression","volume":"12","author":"Glebov","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.ejca.2015.03.015_b0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.prp.2012.07.003","article-title":"Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma","volume":"208","author":"Benedix","year":"2012","journal-title":"Pathol Res Pract"},{"issue":"2","key":"10.1016\/j.ejca.2015.03.015_b0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/DCR.0b013e31823c08b3","article-title":"BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis","volume":"55","author":"Kalady","year":"2012","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.ejca.2015.03.015_b0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00008469-200008000-00006","article-title":"Different expression of some molecular markers in sporadic cancer of the left and right colon","volume":"9","author":"Fric","year":"2000","journal-title":"Eur J Cancer Prev"},{"issue":"3","key":"10.1016\/j.ejca.2015.03.015_b0115","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0959-8049(95)00567-6","article-title":"C-KI-RAS activation and the biological behaviour of proximal and distal colonic adenocarcinomas","volume":"32A","author":"Elnatan","year":"1996","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2015.03.015_b0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00001622-200101000-00013","article-title":"Different mechanisms in the tumorigenesis of proximal and distal colon cancers","volume":"13","author":"Lindblom","year":"2001","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2015.03.015_b0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2015.03.015_b0130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3892\/ijo_00000720","article-title":"Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles","volume":"37","author":"Minoo","year":"2010","journal-title":"Int J Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2015.03.015_b0135","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"Douillard","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejca.2015.03.015_b0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clcc.2011.12.001","article-title":"PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer","volume":"11","author":"Sood","year":"2012","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2015.03.015_b0145","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/annonc\/mdr464","article-title":"PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis","volume":"23","author":"Mao","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2015.03.015_b0150","doi-asserted-by":"crossref","unstructured":"Dienstmann R, Guinney J, Delorenzi M, et al. Colorectal cancer subtyping consortium (CRCSC) identification of a consensus of molecular subtypes. J Clin Oncol 32:5s, 2014 (suppl; abstr 3511). 2014 ASCO Annual Meeting.","DOI":"10.1200\/jco.2014.32.15_suppl.3511"},{"key":"10.1016\/j.ejca.2015.03.015_b0155","doi-asserted-by":"crossref","unstructured":"Missiaglia E, Jacobs B, Di Narzo A, et al. Proximal and distal colon tumors as distinct biologic entities with different prognoses. J Clin Oncol 31, 2013 (suppl; abstr 3526). (2013 ASCO Annual Meeting).","DOI":"10.1200\/jco.2013.31.15_suppl.3526"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915002622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915002622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T03:14:31Z","timestamp":1599016471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915002622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0959804915002622"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.03.015","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}